Research Frontiers Incorporated (REFR) financial statements (2022 and earlier)
Company profile
| Business Address |
240 CROSSWAYS PARK DR WOODBURY, NY 11797-2033 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 6794 - Patent Owners and Lessors (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 3,025 | 2,985 | 3,472 | 4,216 | 4,773 | ||
| Cash and cash equivalents | 270 | 207 | 340 | 4,216 | 4,773 | ||
| Short-term investments | 2,755 | 2,778 | 3,132 | ||||
| Receivables | (1,017) | (972) | (972) | (972) | (972) | ||
| Other undisclosed current assets | 1,941 | 2,484 | 2,002 | 1,795 | 1,627 | ||
| Total current assets: | 3,950 | 4,496 | 4,501 | 5,039 | 5,428 | ||
| Noncurrent Assets | |||||||
| Operating lease, right-of-use asset | 470 | 506 | 543 | 580 | 616 | ||
| Property, plant and equipment | 93 | 100 | 108 | 115 | 122 | ||
| Other noncurrent assets | 34 | 34 | 34 | 34 | 34 | ||
| Total noncurrent assets: | 596 | 640 | 684 | 728 | 772 | ||
| TOTAL ASSETS: | 4,546 | 5,137 | 5,186 | 5,767 | 6,199 | ||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 116 | 85 | 101 | 110 | 60 | ||
| Accounts payable | 66 | 34 | 41 | 42 | 33 | ||
| Accrued liabilities | 49 | 51 | 59 | 69 | 26 | ||
| Other undisclosed current liabilities | 182 | 191 | 200 | 198 | 166 | ||
| Total current liabilities: | 298 | 276 | 301 | 308 | 226 | ||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 464 | 511 | 557 | 603 | 646 | ||
| Operating lease, liability | 464 | 511 | 557 | 603 | 646 | ||
| Other undisclosed noncurrent liabilities | (464) | (511) | (557) | (603) | (646) | ||
| Total noncurrent liabilities: | 511 | 557 | 603 | ||||
| Total liabilities: | 762 | 787 | 858 | 911 | 872 | ||
| Stockholders' equity | |||||||
| Stockholders' equity attributable to parent | 3,784 | 4,350 | 4,328 | 4,856 | 5,327 | ||
| Common stock | 3 | 3 | 3 | 3 | 3 | ||
| Additional paid in capital | 123,468 | 123,251 | 123,251 | 123,251 | 123,165 | ||
| Accumulated deficit | (119,687) | (118,904) | (118,926) | (118,398) | (117,841) | ||
| Total stockholders' equity: | 3,784 | 4,350 | 4,328 | 4,856 | 5,327 | ||
| TOTAL LIABILITIES AND EQUITY: | 4,546 | 5,137 | 5,186 | 5,767 | 6,199 | ||
Income statement (P&L) ($ in thousands)
| 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | ||
|---|---|---|---|---|---|---|
| Revenues | 213 | 723 | 114 | 213 | 131 | |
| Gross profit: | 213 | 723 | 114 | 213 | 131 | |
| Operating expenses | (982) | (706) | (643) | (771) | (1,014) | |
| Operating income (loss): | (769) | 17 | (529) | (558) | (884) | |
| Nonoperating income (Investment Income, Nonoperating) | 4 | 1 | 0 | 1 | ||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (6) | |||||
| Net income (loss): | (775) | 22 | (528) | (557) | (883) | |
| Other undisclosed net loss attributable to parent | (8) | |||||
| Net income (loss) available to common stockholders, diluted: | (783) | 22 | (528) | (557) | (883) | |
Comprehensive Income ($ in thousands)
| 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | ||
|---|---|---|---|---|---|---|
| Net income (loss): | (775) | 22 | (528) | (557) | (883) | |
| Comprehensive income (loss), net of tax, attributable to parent: | (775) | 22 | (528) | (557) | (883) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.